Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Amyloid Solution Inc

Clinical trials sponsored by Amyloid Solution Inc, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Alzheimer's drug candidate AS-S603 begins first human safety tests Results expected Dec 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

Alzheimer's drug candidate AS-S603 begins first human safety tests

Knowledge-focused Recruiting now

This early-phase study is testing the safety and how the body handles a new oral drug called AS-S603, which is being developed to treat Alzheimer's disease. The trial involves 88 healthy volunteers, including Korean and Caucasian adults and Korean elderly people. Participants wil…

Phase 1 • Sponsor: Amyloid Solution Inc • Aim: Knowledge-focused

Last updated Jun 27, 2026 12:32 UTC